{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:50:37Z","timestamp":1648860637268},"reference-count":0,"publisher":"American College of Physicians","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Internal Medicine"],"published-print":{"date-parts":[[2020,9,15]]},"DOI":"10.7326\/acpj202009150-035","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T21:03:12Z","timestamp":1600117392000},"page":"JC35","source":"Crossref","is-referenced-by-count":0,"title":["5 classes of antihypertensive drugs were not linked to positive COVID-19 test results or severe COVID-19"],"prefix":"10.7326","volume":"173","author":[{"given":"Thomas","family":"Fekete","sequence":"first","affiliation":[{"name":"Lewis Katz School of Medicine of Temple University, Philadelphia, Pennsylvania, USA (T.F.)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4285","container-title":["Annals of Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T19:44:32Z","timestamp":1603309472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.acpjournals.org\/doi\/10.7326\/ACPJ202009150-035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,9,15]]}},"alternative-id":["10.7326\/ACPJ202009150-035"],"URL":"https:\/\/doi.org\/10.7326\/acpj202009150-035","relation":{},"ISSN":["0003-4819","1539-3704"],"issn-type":[{"value":"0003-4819","type":"print"},{"value":"1539-3704","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]}}}